Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/29356
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorMOREIRA, Rodrigo C.-
dc.contributor.authorMILL, Jose G.-
dc.contributor.authorGRINSZTEJN, Beatriz-
dc.contributor.authorVELOSO, Valdilea-
dc.contributor.authorFONSECA, Maria de Jesus-
dc.contributor.authorGRIEP, Rosane H.-
dc.contributor.authorBENSENOR, Isabela-
dc.contributor.authorCARDOSO, Sandra W.-
dc.contributor.authorLOTUFO, Paulo-
dc.contributor.authorCHOR, Dora-
dc.contributor.authorPACHECO, Antonio G.-
dc.date.accessioned2018-11-21T17:00:05Z-
dc.date.available2018-11-21T17:00:05Z-
dc.date.issued2018-
dc.identifier.citationJAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, v.78, n.1, p.73-81, 2018-
dc.identifier.issn1525-4135-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/29356-
dc.description.abstractIntroduction: Aortic stiffness measured by carotid-femoral pulse wave velocity (cf-PWV) is a marker of subclinical atherosclerosis. We propose to assess whether HIV infection is associated with arterial stiffness and their determinants in HIV-infected subjects. Methods: We compared data from an HIV cohort (644 patients, HIV+) in Rio de Janeiro with 2 groups: 105 HIV-negative (HIV-) individuals and 14,873 participants of the ELSA-Brasil study. We used multivariable linear regression to investigate factors associated with cf-PWV and whether HIV was independently associated with aortic stiffness and propensity score weighting to control for imbalances between groups. Results: From 15,860 participants, cf-PWV was obtained in 15,622 (98.5%). Median age was 51 (interquartile range 45-58), 44.41 (35.73, 54.72), and 43.60 (36.01, 50.79) years (P < 0.001), and median cf-PWV (m/s; interquartile range) was 9.0 (8.10, 10.20), 8.70 (7.90, 10.20), and 8.48 (7.66, 9.40) for ELSA-Brasil, HIV- and HIV+, respectively (P < 0.001). In the final weighted multivariable models, HIV group was not associated with cf-PWV when compared either with ELSA-Brasil [beta = -0.05; 95% confidence interval (CI) = -0.23; P = 0.12; P = 0.52] or with the HIV- groups (beta = 0.10; 95% CI = -0.10; 0, 31; P = 0.32). Traditional risk factors were associated with higher cf-PWV levels in the HIV+ group, particularly waist-tohip ratio (beta = 0.20; 95% CI = 0.10; 0.30; P < 0.001, result per one SD change). Conclusions: HIV infection was not associated with higher aortic stiffness according to our study. In HIV-infected subjects, the stiffness of large arteries is mainly associated with traditional risk factors and not to the HIV infection per se.-
dc.description.sponsorshipFundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/102398/2009, E-26/201.471/2014]-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico [01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ, 407446/2012-5, 304614/2012-2]-
dc.description.sponsorshipPrograma Estrategico de Apoio a Pesquisa em Saude [407446/2012-5]-
dc.language.isoeng-
dc.publisherLIPPINCOTT WILLIAMS & WILKINS-
dc.relation.ispartofJAIDS-Journal of Acquired Immune Deficiency Syndromes-
dc.rightsrestrictedAccess-
dc.subjectpeople living with HIV-
dc.subjectcardiovascular risk factors-
dc.subjectarterial stiffness-
dc.subject.otherhuman-immunodeficiency-virus-
dc.subject.otheractive antiretroviral therapy-
dc.subject.otherincreased arterial stiffness-
dc.subject.otheracute myocardial-infarction-
dc.subject.otherpulse-wave velocity-
dc.subject.otherall-cause-
dc.subject.otherindividuals-
dc.subject.othermortality-
dc.subject.otherdisease-
dc.subject.otherevents-
dc.titleHIV Infection Is Not Associated With Aortic Stiffness. Traditional Cardiovascular Risk Factors Are the Main Determinants-Cross-sectional Results of INI-ELSA-BRASIL-
dc.typearticle-
dc.rights.holderCopyright LIPPINCOTT WILLIAMS & WILKINS-
dc.contributor.groupauthorINI ELSA BRASIL-
dc.identifier.doi10.1097/QAI.0000000000001646-
dc.identifier.pmid29624545
dc.subject.wosImmunology-
dc.subject.wosInfectious Diseases-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalMOREIRA, Rodrigo C.:Inst Nacl Infectol Evandro Chagas, Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; Fundacao Oswaldo Cruz, Programa Computacao Cient, Rio De Janeiro, Brazil-
hcfmusp.author.externalMILL, Jose G.:Univ Fed Espirito Santo, Dept Ciencias Fisiol, Vitoria, Brazil-
hcfmusp.author.externalGRINSZTEJN, Beatriz:Inst Nacl Infectol Evandro Chagas, Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil-
hcfmusp.author.externalVELOSO, Valdilea:Inst Nacl Infectol Evandro Chagas, Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil-
hcfmusp.author.externalFONSECA, Maria de Jesus:Fundacao Oswaldo Cruz, Dept Epidemiol & Metodos Quantitat Saude, Rio De Janeiro, Brazil-
hcfmusp.author.externalGRIEP, Rosane H.:Fundacao Oswaldo Cruz, Lab Hlth & Environm Educ, Rio De Janeiro, Brazil-
hcfmusp.author.externalCARDOSO, Sandra W.:Inst Nacl Infectol Evandro Chagas, Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil-
hcfmusp.author.externalCHOR, Dora:Fundacao Oswaldo Cruz, Dept Epidemiol & Metodos Quantitat Saude, Rio De Janeiro, Brazil-
hcfmusp.author.externalPACHECO, Antonio G.:Fundacao Oswaldo Cruz, Programa Computacao Cient, Rio De Janeiro, Brazil-
hcfmusp.description.beginpage73-
hcfmusp.description.endpage81-
hcfmusp.description.issue1-
hcfmusp.description.volume78-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000444631200012-
hcfmusp.origem.id2-s2.0-85064126828
hcfmusp.publisher.cityPHILADELPHIA-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAdler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60-
hcfmusp.relation.referenceAquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294-
hcfmusp.relation.referenceBaena CP, 2015, AM J HYPERTENS, V28, P966, DOI 10.1093/ajh/hpu298-
hcfmusp.relation.referenceBaker JV, 2009, JAIDS-J ACQ IMM DEF, V52, P25, DOI 10.1097/QAI.0b013e3181b02e6a-
hcfmusp.relation.referenceBaldo MP, 2017, J AM HEART ASS, V6-
hcfmusp.relation.referenceBensenor IM, 2013, REV SAUDE PUBL, V47, P37, DOI 10.1590/S0034-8910.2013047003780-
hcfmusp.relation.referenceBraitstein P, 2006, LANCET, V367, P817-
hcfmusp.relation.referenceBrito Ana Maria de, 2005, Braz J Infect Dis, V9, P9, DOI 10.1590/S1413-86702005000100004-
hcfmusp.relation.referenceCalcagno CdM V, 2010, J STAT SOFTW, V34-
hcfmusp.relation.referenceCharakida M, 2009, ANTIVIR THER, V14, P1075, DOI 10.3851/IMP1437-
hcfmusp.relation.referenceD'Ascenzo F, 2012, EUR HEART J, V33, P875, DOI 10.1093/eurheartj/ehr456-
hcfmusp.relation.referencede Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026-
hcfmusp.relation.referenceEcheverria P, 2014, JAIDS-J ACQ IMM DEF, V65, P50, DOI 10.1097/QAI.0b013e3182a97c17-
hcfmusp.relation.referenceEira M, 2012, ARQ BRAS CARDIOL, V99, P1100, DOI 10.1590/S0066-782X2012005000110-
hcfmusp.relation.referenceEl-Sadr WM, 2006, NEW ENGL J MED, V355, P2283-
hcfmusp.relation.referenceFerdinand KC, 2006, AM J CARDIOL, V97, p12A, DOI 10.1016/j.amjcard.2005.11.011-
hcfmusp.relation.referenceFreiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728-
hcfmusp.relation.referenceGrinsztejn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059768-
hcfmusp.relation.referenceHo D, 2017, MATCHIT NONPARAMETRI-
hcfmusp.relation.referenceHo JE, 2010, AIDS, V24, P1897, DOI 10.1097/QAD.0b013e32833bee44-
hcfmusp.relation.referenceKlein DB, 2015, CLIN INFECT DIS, V60, P1278, DOI 10.1093/cid/civ014-
hcfmusp.relation.referenceKooij KW, 2016, JAIDS-J ACQ IMM DEF, V73, P55, DOI 10.1097/QAI.0000000000001024-
hcfmusp.relation.referenceLaurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236-
hcfmusp.relation.referenceLedergerber B, 2007, CLIN INFECT DIS, V45, P111, DOI 10.1086/518619-
hcfmusp.relation.referenceLekakis J, 2009, AM J HYPERTENS, V22, P828, DOI 10.1038/ajh.2009.90-
hcfmusp.relation.referenceLevey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006-
hcfmusp.relation.referenceLundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816-
hcfmusp.relation.referenceLeite LHM, 2017, ARCH CARDIOVASC DIS, V110, P495, DOI 10.1016/j.acvd.2017.03.001-
hcfmusp.relation.referenceMaia-Leite LH, 2016, J HYPERTENS, V34, P1338, DOI 10.1097/HJH.0000000000000957-
hcfmusp.relation.referenceMcCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753-
hcfmusp.relation.referenceMinisterio da Saude-Secretaria de Vigilancia em Saude-Programa Nacional de DST, 2014, B EP HIV AIDS-
hcfmusp.relation.referenceMonteiro P, 2012, BRAZ J MED BIOL RES, V45, P818, DOI 10.1590/S0100-879X2012007500116-
hcfmusp.relation.referenceMorris AA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.002154-
hcfmusp.relation.referenceMugavero MJ, 2011, CLIN INFECT DIS, V53, P927, DOI 10.1093/cid/cir526-
hcfmusp.relation.referenceNou E, 2016, AIDS, V30, P1495, DOI 10.1097/QAD.0000000000001109-
hcfmusp.relation.referencePacheco AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158999-
hcfmusp.relation.referencePacheco AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117461-
hcfmusp.relation.referencePacheco AG, 2009, JAIDS-J ACQ IMM DEF, V51, P624, DOI 10.1097/QAI.0b013e3181a4ecf5-
hcfmusp.relation.referencePaula AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094636-
hcfmusp.relation.referencede Miranda EJFP, 2017, AM J HYPERTENS, V30, P81, DOI 10.1093/ajh/hpw117-
hcfmusp.relation.referencePetoumenos K, 2011, HIV MED, V12, P412, DOI 10.1111/j.1468-1293.2010.00901.x-
hcfmusp.relation.referenceQuiros-Roldan E, 2016, AIDS CARE, V28, P1551, DOI 10.1080/09540121.2016.1198750-
hcfmusp.relation.referenceSchmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027-
hcfmusp.relation.referenceSevastianova K, 2005, ANTIVIR THER, V10, P925-
hcfmusp.relation.referenceTeam R. C., 2015, R LANG ENV STAT COMP-
hcfmusp.relation.referenceTriant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190-
hcfmusp.relation.referenceUsach I, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18567-
hcfmusp.relation.referenceVlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061-
hcfmusp.relation.referenceWilson DP, 2013, HIV MED, V14, P193, DOI 10.1111/hiv.12006-
hcfmusp.relation.referenceZeng Y, 2010, CHINESE MED J-PEKING, V123, P3396, DOI 10.3760/cma.j.issn.0366-6999.2010.23.004-
dc.description.indexMEDLINE-
dc.identifier.eissn1077-9450-
hcfmusp.citation.scopus3-
hcfmusp.scopus.lastupdate2022-07-22-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - LIM/20
LIM/20 - Laboratório de Terapêutica Experimental

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_MOREIRA_HIV_Infection_Is_Not_Associated_With_Aortic_Stiffness_2018.PDF
  Restricted Access
publishedVersion (English)173.52 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.